Caribou Biosciences, Inc. (CRBU) — Capital Expenditures
| Fiscal Year | Capital Expenditures | Change YoY |
|---|---|---|
| 2025 | $1.36M | -72.2% |
| 2024 | $4.88M | -58.0% |
| 2023 | $11.61M | +79.9% |
| 2022 | $6.45M | +204.3% |
| 2021 | $2.12M | +569.1% |
| 2020 | $317.0K | -64.1% |
| 2019 | $884.0K | — |
| Fiscal Year | Capital Expenditures | Change YoY |
|---|---|---|
| 2025 | $1.36M | -72.2% |
| 2024 | $4.88M | -58.0% |
| 2023 | $11.61M | +79.9% |
| 2022 | $6.45M | +204.3% |
| 2021 | $2.12M | +569.1% |
| 2020 | $317.0K | -64.1% |
| 2019 | $884.0K | — |